Tandem Technology to Raise $100 Million for Prescription Automation

January 26, 2026 - 18:47

Aiming to revolutionize a critical yet often cumbersome part of healthcare, HealthTech startup Tandem Technology is embarking on a significant capital raise. The company is seeking to secure approximately $100 million in new funding, according to recent reports. This financial injection is intended to accelerate the development and deployment of its automated prescription management systems.

The startup's core mission is to streamline the complex journey of a prescription from a clinician's decision to a patient's hands. By leveraging advanced automation and software, Tandem aims to eliminate administrative bottlenecks, reduce errors, and speed up fulfillment times within pharmacies and healthcare institutions. This process traditionally involves multiple manual verification steps, prior authorizations, and coordination between doctors, insurers, and pharmacists, often leading to delays for patients.

The proposed funding round underscores growing investor confidence in technologies that address healthcare's operational inefficiencies. A successful raise would provide Tandem with substantial resources to expand its engineering team, enhance its platform's capabilities, and pursue broader market adoption. The initiative highlights an increasing focus within the HealthTech sector on solving back-end logistical challenges, with the ultimate goal of improving patient experience and freeing up medical professionals to focus more on direct care. The company's progress is being watched as a potential benchmark for innovation in pharmacy operations and healthcare administration.